Skip to content
Open access

Temporal Progression of Auditory Brainstem Dysfunction and Behavioral Phenotypes in Mouse Models of Tauopathy

Aug 2026 · Journal of Neuroscience · Vol 46 · 0 citations
Medicine

TL;DR

The divergent temporal patterns of ABR alterations across genotypes suggest that genetic context, particularly ApoE4, modulates the progression of tau-driven circuit dysfunction, highlighting ABR as a potential noninvasive biomarker for early tau-related neurodegenerative disease.

Abstract

Cognitive decline in Alzheimer’s disease and related dementias (AD/ADRD) frequently cooccurs with motor and sensory processing impairments. While auditory abnormalities were reported in beta-amyloid-based models before cognitive decline, the effects of tau pathology on auditory circuit function remain poorly understood. The PS19 mouse model expressing the P301S tau mutation exhibits tau pathology associated with frontotemporal dementia. When combined with the humanized ApoE ɛ4 allele, these mice show accelerated tau accumulation and neurodegeneration. We investigated the temporal progression of auditory and behavioral deficits in PS19 and ApoE4/PS19 mice of either sex at 3 and 7 months. Auditory processing was assessed using auditory brainstem response (ABR) recordings, while anxiety-like and motor behaviors were evaluated using the elevated plus maze and rotarod assays. PS19 mice exhibited auditory pathway dysfunction at 3 months, characterized by reduced and delayed neural responses to acoustic stimuli. These auditory deficits occurred without detectable behavioral changes in anxiety- or motor-related measures. By 7 months, cochlear nucleus-derived ABR activity shifted from an initial reduction to elevation relative to controls, suggesting compensatory hyperexcitability. In contrast, ApoE4/PS19 mice showed reduced ABR amplitudes and shortened response latencies that persisted with age, accompanied by altered anxiety-like behavior and motor performance. Together, these results demonstrate that auditory pathway dysfunction may represent an early marker of tau pathology preceding behavioral impairment. The divergent temporal patterns of ABR alterations across genotypes suggest that genetic context, particularly ApoE4, modulates the progression of tau-driven circuit dysfunction, highlighting ABR as a potential noninvasive biomarker for early tau-related neurodegenerative disease.

Read PDF

Similar papers

Sep 2026

Auditory brainstem response deficits precede and are associated with subsequent auditory cortical amyloid burden in male APP/PS1 mice.

BackgroundAuditory dysfunction is considered one of the early manifestations of Alzheimer's disease (AD). However, its evolutionary characteristics with the progression of AD have not been fully studied, and the temporal relationship between this sensory impairment and the typical pathology of the disease is unclear.Ob...

Yin-Pei Luo, Li-Ping Chen, Shui-Gui Yin et al. · 0 citations
Feb 2026

Pathogenic tau in the mouse locus coeruleus produces noradrenergic hyperactivity and neuropsychiatric phenotypes reminiscent of early Alzheimer’s disease

It is demonstrated that pTau triggers phenotypes reflective of LC-NE hyperactivity in the early stages of AD pathogenesis, laying the foundation for the development of LC-based disease-modifying therapies to address neuropsychiatric manifestations.

Anuradha Korukonda, Harris E. Blankenship, K. Kam et al. · 3 citations
Open access Aug 2026

Impact of stroke on respiratory function and amyloid-β pathology in Tg-2576 mice

Background Stroke is a well-established risk factor for dementia, and many patients with Alzheimer's disease exhibit mixed neuropathology that includes both ischemic injury and amyloid-β (Aβ) accumulation. Breathing disturbances, such as apnea, have also been linked to cognitive dysfunction and accelerated dementia pro...

Yu-Xing Zhang, Ahmad El Hamamy, Zahid Iqbal et al. · 0 citations
Open access Sep 2026

Progressive behavioral and cognitive decline in Drosophila harboring AD-associated APOE4 variants

A scalable model to dissect APOE-dependent mechanisms and identify therapeutic targets in AD is established, establishing a scalable model of disease pathogenesis and highlighting a central role for oxidized lipid metabolism in AD.

S. Biglari, Eshani Yeragi, David Bamisaye et al. · 0 citations
Open access Sep 2026

Human P301L tau expression in mice alters neuronal excitability independent of neurodegeneration

Data suggest an increase in neuronal excitability in P301L mice compared with WT, but that this phenotype is not correlated with the age-dependent accumulation of AT8-labeled tau aggregates and the accompanying neuroinflammation.

K. Dunton, Hugo Monchal, Brie E Achorn et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.